This inventor holds 1 USPTO granted patent. Top assignee: Stichting Radboud Universiteit. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Emiel Rossing: Innovator in Medicinal Chemistry
Introduction
Emiel Rossing is a notable inventor based in Nijmegen, Netherlands. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on fluorinated hexoses. His research focuses on developing compounds that have the potential to impact the treatment of various diseases.
Latest Patents
Emiel Rossing holds a patent for a new class of compounds based on a hexose featuring at least two 6-fluorides. This invention is particularly relevant as it relates to inhibitors of 4,6-dehydratase enzymes. Such inhibitors are suitable for use as medicaments, especially for treating, preventing, or delaying cancer, tumor metastasis, inflammation, infections, or genetic disorders. He has 1 patent to his name.
Career Highlights
Rossing is affiliated with Stichting Radboud Universiteit, where he conducts his research and development. His work has garnered attention for its potential applications in the medical field, showcasing his commitment to advancing healthcare solutions.
Collaborations
Emiel Rossing has collaborated with notable colleagues, including Johan Franciscus Adrianus Pijnenborg and Thomas Jan Boltje. These partnerships have contributed to the depth and breadth of his research endeavors.
Conclusion
Emiel Rossing's innovative work in the field of medicinal chemistry highlights his role as a key inventor in developing new therapeutic compounds. His contributions are paving the way for advancements in treating serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile